Mutations in TP53 and KLF6 in Prostate Cancer
Author Information
Author(s): Mühlbauer K-R, Gröne H-J, Ernst T, Gröne E, Tschada R, Hergenhahn M, Hollstein M
Primary Institution: German Cancer Research Center (Deutsches Krebsforschungszentrum)
Hypothesis
Are KLF6 mutations common in prostate cancer?
Conclusion
KLF6 mutations are uncommon in prostate cancer, while TP53 mutations were found in 12% of the tumors analyzed.
Supporting Evidence
- KLF6 mutations were not found in any of the 32 tumor samples analyzed.
- TP53 mutations were identified in 12% of the tumors examined.
- The study's findings contrast with previous reports suggesting KLF6 mutations are common in prostate cancer.
Takeaway
The study looked at prostate cancer samples to see if a gene called KLF6 had mutations. They found that KLF6 mutations are not very common, but another gene, TP53, had some mutations.
Methodology
Tumor samples from 32 patients were analyzed for mutations in KLF6 and TP53 using various sequencing methods.
Limitations
The study only examined a limited number of tumor samples and may not represent all prostate cancer cases.
Participant Demographics
Patients were from Germany, with most having a Gleason score of 7 or higher.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website